Chemotherapy is more about MoneyIf scientists/researchers found a magic cure for cancer we could stop spending all those billions of dollars a year in funding, and the researchers could all become redundant along with 50% of the doctors and 50% of the hospital staff and 50% the hospitals could be closed. If your job paid you a 6 figure income to find a way to make yourself and your job unnecessary as soon as possible, but with no time frame stipulated, how hard would you try and how how soon would you make yourself reducdant?
It is startling to discover what chemotherapy drugs are made from. The first ones were made from mustard gas exactly like the weapons that killed so many soldiers in WW I, eventually outlawed by the Geneva Conventions. In the 1930s, Memorial Sloan-Kettering quietly began to treat breast cancer with these mustard gas derivatives. No one was cured. Most of the medical profession at that time regarded such "treatment" of malignant disease as charlatanism. Nitrogen mustard chemotherapy trials were conducted at Yale around 1943. 160 patients were treated. No one was cured. The beginning of the hype that promised to cure all cancer by means of chemo drugs, came as an offshoot of the postwar excitement with the success of antibiotics and the sulfa drugs. Caught up in the heady atmosphere of visions of money and power in vanquishing cancer, Memorial Sloan-Kettering began to make extravagant claims that to this day have never been realized. Some 400,000 "cytotoxins" were tested by Sloan-Kettering and the National Cancer Institute. The criteria in order to be tested were: will the toxin kill some of the tumor cells before it kills the patient. That's it! Many were brand new synthetic compounds. But thousands of others were existing poisons which were simply refined. Finally about 50 drugs made the cut, and are the basis of today's chemotherapy medicine cabinet. One of these 50 is a sheep-deworming agent known as Levamisole. With no major clinical trial ever showing significant increased long term survival with Levamisole, it is still a standard chemotherapy agent even today! The weirdness is, Levamisole was included for its "immune system modulation" properties. However, its major toxicities include: Some immune booster! A major study of Levamisole written up in the British Journal of Cancer showed almost double the survival rate using a placebo instead of Levamisole! The utter mystification over why this poison continues to be used as a standard component of chemo cocktails can be cleared up by considering one simple fact: when Levamisole was still a sheep de-wormer, it cost $1 per year. When the same amount was suddenly upgraded to a cancer drug given to humans, now it costs $1200 per year. Thank you, Johnson & Johnson. (Los Angeles Times 11 Sep 93.) The cancer industry is probably the most prosperous business in the United States. In 2014, there will be an estimated 1,665,540 new cancer cases diagnosed and 585,720 cancer deaths in the US. $6 billion of tax-payer funds are cycled through various federal agencies for cancer research, such as the National Cancer Institute (NCI). The NCI states that the medical costs of cancer care are $125 billion, with a projected 39 percent increase to $173 billion by 2020.
(Health Impact News 2014)
"Private-practice oncologists typically derive two-thirds of their income from selling chemotherapy." (Wonder how much that effects their choice. If a patient has no hope of survival do you pump them full of Chemo any way? The most expensive? Research into costing and perscribing shows this really does happen.)
(Journal of the National Cancer Institute 2001; 93:491)
A 1994 major study of Levamisole written up in the British Journal of Cancer showed almost double the survival rate using a placebo instead of Levamisole!
Lancet 2000; 355: 1588-1596. Primary surgical treatment of colorectal cancer is possible in about 70% of patients but approximately half of them will eventually develop incurable recurrent disease. Between 1994 and 1997, 4927 post operative patients researched Levamisole. 1776 had recurrences and 1576 died. Survival was worse with Levamisole than placebo (69% vs. 71% at 3 years.). It was concluded that addition of Levamisole to chemotherapy regimes for colorectal cancer does not delay recurrence or improve survival.
The British Journal of Dermatology, Volume 153 Issue 1 Page 163 - July 2005 publishes the recent research result which includes: “Conclusion: The study indicates that Levamisole is not as effective in arresting disease progression as was observed in a previous open study. A study with a larger sample size is necessary to determine if Levamisole is truly superior to placebo in this respect.”
|
Levamisole has now been researched and administered to patients for more than 60 years. It is only one example of many. The doctors who started the research will all be deab by now, but the company profit lives on under the guise on research even though it has SCIENTIFICALLY PROVEN to KILL MORE PEOPLE THAN THE PLACEBO!